BioCentury
ARTICLE | Product Development

Actiq sales

September 22, 2003 7:00 AM UTC

Reformulated pain drugs can enjoy significant sales growth. Cephalon (CEPH) gained the rights to breakthrough cancer pain drug Actiq transmucosal fentanyl in October 2000 when it acquired Anesta in a ...